A judge has suspended a Food & Drug Administration rule requiring that women be seen by a doctor before abortion-inducing drugs are dispensed to them to have an at-home abortion during the COVID-19 pandemic.
U.S. District Judge Theodore Chuang issued the decision Monday, suspending the FDA rule, arguing that the in-person requirement presented a “substantial obstacle” to women seeking an abortion.
“Particularly in light of the limited timeframe during which a medication abortion or any abortion must occur, such infringement on the right to an abortion would constitute irreparable harm,” wrote Chuang, as reported by The Associated Press.
“By causing certain patients to decide between forgoing or substantially delaying abortion care, or risking exposure to COVID-19 for themselves, their children, and family members, the In-Person Requirements present a serious burden to many abortion patients.”
In a medical abortion, women are given two drugs: mifepristone (RU-486), and misoprostol. Mifepristone works by blocking the effects of the natural pregnancy hormone progesterone. Misoprostol induces contractions and a miscarriage.
The demand to suspend the FDA regulation stemmed from legal action taken in May by the American College of Obstetricians and Gynecologists and other groups, noted the AP.
Many pro-life OB/GYNs are no longer members of ACOG and instead have joined a separate organization, the American Association of Pro-Life Obstetricians and Gynecologists, after they said ACOG began advocating for abortion on demand and abortion for minors without parental consent.
Click here to read more.
SOURCE: Christian Post, Michael Gryboski
Like this:
Like Loading...
Related
BCNN1 WP 